JP2025505642A5 - - Google Patents
Info
- Publication number
- JP2025505642A5 JP2025505642A5 JP2024546404A JP2024546404A JP2025505642A5 JP 2025505642 A5 JP2025505642 A5 JP 2025505642A5 JP 2024546404 A JP2024546404 A JP 2024546404A JP 2024546404 A JP2024546404 A JP 2024546404A JP 2025505642 A5 JP2025505642 A5 JP 2025505642A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antibody
- administered
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263307375P | 2022-02-07 | 2022-02-07 | |
| US63/307,375 | 2022-02-07 | ||
| US202263389042P | 2022-07-14 | 2022-07-14 | |
| US63/389,042 | 2022-07-14 | ||
| PCT/IB2023/051076 WO2023148702A1 (en) | 2022-02-07 | 2023-02-07 | Methods for reducing infusion-related reactions in patients treated with egfr/met bispecific antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505642A JP2025505642A (ja) | 2025-02-28 |
| JP2025505642A5 true JP2025505642A5 (https=) | 2026-01-21 |
Family
ID=85278233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546404A Pending JP2025505642A (ja) | 2022-02-07 | 2023-02-07 | Ｅｇｆｒ／ｍｅｔ二重特異性抗体で処置された患者における注入関連反応を低減するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230250195A1 (https=) |
| EP (1) | EP4476255A1 (https=) |
| JP (1) | JP2025505642A (https=) |
| KR (1) | KR20240146675A (https=) |
| AU (1) | AU2023215753A1 (https=) |
| CA (1) | CA3251417A1 (https=) |
| IL (1) | IL314756A (https=) |
| MX (1) | MX2024009701A (https=) |
| TW (1) | TW202342057A (https=) |
| WO (1) | WO2023148702A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025185602A1 (en) * | 2024-03-05 | 2025-09-12 | Hansoh Bio Llc | Immunoconjugates and pharmaceutical uses thereof |
| WO2026038160A1 (en) * | 2024-08-13 | 2026-02-19 | Janssen Biotech, Inc. | Methods for reducing infusion-related reactions in patients treated with egfr/met bispecific antibodies |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ES2156149T3 (es) | 1992-12-04 | 2001-06-16 | Medical Res Council | Proteinas de union multivalente y multiespecificas, su fabricacion y su uso. |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| EP3042964A1 (en) | 2004-06-04 | 2016-07-13 | Genentech, Inc. | Egfr mutations |
| WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| AU2006232287B2 (en) | 2005-03-31 | 2011-10-06 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| PT1999154E (pt) | 2006-03-24 | 2013-01-24 | Merck Patent Gmbh | Domínios proteicos heterodiméricos modificados |
| JP2009541275A (ja) | 2006-06-22 | 2009-11-26 | ノボ・ノルデイスク・エー／エス | 二重特異性抗体の生産 |
| KR20100058509A (ko) | 2007-07-31 | 2010-06-03 | 메디뮨 엘엘씨 | 다중특이적 에피토프 결합 단백질 및 이의 용도 |
| AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
| US8242247B2 (en) | 2007-12-21 | 2012-08-14 | Hoffmann-La Roche Inc. | Bivalent, bispecific antibodies |
| US8227577B2 (en) | 2007-12-21 | 2012-07-24 | Hoffman-La Roche Inc. | Bivalent, bispecific antibodies |
| US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
| WO2010129304A2 (en) | 2009-04-27 | 2010-11-11 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| HRP20241208T1 (hr) | 2010-04-20 | 2024-11-22 | Genmab A/S | Heterodimerni proteini koji sadrže fc fragment protutijela i postupci za njihovu proizvodnju |
| ES2758994T3 (es) | 2010-11-05 | 2020-05-07 | Zymeworks Inc | Diseño anticuerpo heterodimérico estable con mutaciones en el dominio Fc |
| SG194802A1 (en) * | 2011-05-16 | 2013-12-30 | Genzyme Corp | Induction of immune tolerance by using methotrexate |
| BR112014010580B1 (pt) | 2011-11-04 | 2021-01-12 | Zymeworks, Inc. | constructo de fc heteromultimérico isolado, composição, uso de um constructo de fc heteromultimérico isolado, composição de ácido nucléico e método para expressar o constructo de fc heteromultimérico isolado |
| MX361088B (es) | 2012-11-21 | 2018-11-26 | Janssen Biotech Inc | Anticuerpos del receptor del factor de crecimiento epidérmico aislado/del receptor del factor de crecimiento de hepatocitos (egfr/c-met) biespecíficos. |
| HUE054848T2 (hu) | 2014-10-13 | 2021-09-28 | Yuhan Corp | Vegyületek és készítmények EGFR mutáns kináz aktivitás módosítására |
| KR102771603B1 (ko) | 2016-11-17 | 2025-02-24 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | Egfr 또는 her2 엑손 20 돌연변이를 갖는 암 세포에 대한 항종양 활성을 갖는 화합물 |
| US11879013B2 (en) * | 2019-05-14 | 2024-01-23 | Janssen Biotech, Inc. | Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitors |
| AU2020284706A1 (en) * | 2019-05-28 | 2021-12-16 | Alligator Bioscience Ab | Method of providing safe administration of an anti-CD40 antibody |
| WO2021245238A1 (en) * | 2020-06-04 | 2021-12-09 | Bioinvent International Ab | Improving antibody tolerability associated with intravenous administration |
| US20230174677A1 (en) * | 2021-11-16 | 2023-06-08 | Janssen Biotech, Inc. | Use of Approved Bispecific EGFR and Met Specific Antibody Drug Product to Treat Non-Small Cell Lung Cancer (NSCLCL) |
-
2023
- 2023-02-06 TW TW112104066A patent/TW202342057A/zh unknown
- 2023-02-07 KR KR1020247029434A patent/KR20240146675A/ko active Pending
- 2023-02-07 EP EP23705671.8A patent/EP4476255A1/en active Pending
- 2023-02-07 CA CA3251417A patent/CA3251417A1/en active Pending
- 2023-02-07 AU AU2023215753A patent/AU2023215753A1/en active Pending
- 2023-02-07 US US18/106,531 patent/US20230250195A1/en active Pending
- 2023-02-07 IL IL314756A patent/IL314756A/en unknown
- 2023-02-07 WO PCT/IB2023/051076 patent/WO2023148702A1/en not_active Ceased
- 2023-02-07 JP JP2024546404A patent/JP2025505642A/ja active Pending
-
2024
- 2024-08-06 MX MX2024009701A patent/MX2024009701A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12258411B2 (en) | Anti-CCR8 antibodies and uses thereof | |
| KR101931591B1 (ko) | 항－ｉｌ－２３ 항체 | |
| US8552157B2 (en) | c-Kit antibodies and uses thereof | |
| JP2023515271A5 (https=) | ||
| JP2019531273A5 (https=) | ||
| US20140186377A1 (en) | Prostaglandin e2 binding proteins and uses thereof | |
| TW202126693A (zh) | 標靶bcma的抗體、雙專一性抗體及其用途 | |
| JP2017514461A5 (https=) | ||
| RU2013155906A (ru) | Антитела анти-angptl3 и их применение | |
| JP2025505642A5 (https=) | ||
| JP2023542291A5 (https=) | ||
| JP2024544523A5 (https=) | ||
| JP2022512875A5 (https=) | ||
| WO2017059813A1 (zh) | 抗乙肝表面抗原的抗体及其用途 | |
| JP2025500784A5 (https=) | ||
| JP2024516698A5 (https=) | ||
| FI4244252T3 (fi) | Kroonisen obstruktiivisen keuhkosairauden hoito anti-interleukiini-33-vasta-aineella | |
| JP6663910B2 (ja) | 抗ＴＮＦ−α抗体療法を受けた乾癬患者を治療するための方法 | |
| JP2021523138A5 (https=) | ||
| JP2024525870A5 (https=) | ||
| WO2020148554A1 (en) | Antibodies to ebola virus glycoprotein | |
| JP2024538140A5 (https=) | ||
| JP2021529766A5 (https=) | ||
| JP2017515843A5 (https=) | ||
| JP2023546504A5 (https=) |